Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Alkermes (NASDAQ:ALKS) through any online brokerage.
Other companies in Alkermes’s space includes: Immunovant Inc (NASDAQ:IMVT), Cogent Biosciences Inc (NASDAQ:COGT), Celcuity Inc (NASDAQ:CELC), Centessa Pharmaceuticals PLC (NASDAQ:CNTA) and Xenon Pharmaceuticals Inc (NASDAQ:XENE).
Alkermes has a consensus price target of $42.16.
The stock price for Alkermes (NASDAQ: ALKS) is $34.84 last updated April 2, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Alkermes.
Alkermes does not have any upcoming earnings scheduled.
There is no upcoming split for Alkermes.
Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.